Contact Details
- Phone
- +64 3 479 7708
- roslyn.kemp@otago.ac.nz
University Links
- Position
- Professor
- Department
- Department of Microbiology and Immunology
- Qualifications
- BSc(Hons) PhD
- Research summary
- Applied and molecular immunology, cancer immunobiology, vaccines – immunology and technology
Research
My research focuses on T cells as mediators of anti-tumour immunity and inflammation. Specifically, we study the role of inflammation and the unique features of different subsets of T cells and myeloid cells, focussing on cancer and gut-specific immune responses; and how these cell subsets are involved in patient outcome.
We are currently looking at T cell and myeloid cell subsets in colorectal cancer and inflammatory bowel disease to improve diagnosis, prognosis and treatment. We are generating site-specific T cell memory using novel slow release vaccines and analysing the molecular signalling pathways required to maintain these populations.
Research projects
My current areas of research are mucosal and tumour immune responses, inflammation and T cell memory.
Mucosal Immune Responses in Cancer and Inflammatory Diseases
- Using immune responses in the tumour to predict patient outcome in colorectal cancer
- Investigating T cell responses in inflammatory bowel disease patients
- Using human intestinal organoids to model the gut immune response
- Heterogeneity and plasticity of T cell subsets in the gut mucosa and their influence on anti-tumour immune responses
- Generating gut-specific memory T cells through vaccination
- Development of new analytical tools to study high dimensional immune data
CD8+ T Cell Memory
- Interactions between na?ve and memory T cell populations
- Vaccination strategies to generate effective T cell memory populations
Molecular Pathways controlling T cells
- Molecular signals controlling memory T cell development and maintenance
- Signalling pathways in tumour immune responses
Publications
Longoni, A., Major, G. S., Arnold, S., Tomkins, S., Spessot, E., Loeffler, S., … Harte, J., Kemp, R., … Hooper, G. J., Woodfield, T. B. F., Kieser, D. C., & Lim, K. S. (2026). Characterization of an injectable poly(vinyl alcohol)-gelatin hydrogel for growth factor delivery in an orthopedic application. Advanced Healthcare Materials. Advance online publication. doi: 10.1002/adhm.202504224 Journal - Research Article
King, M. R., Kemp, R. A., & Gadeock, S. (2025). Type I interferons in inflammatory bowel diseases: Balancing barrier integrity, repair and inflammation in the intestinal epithelium [Mini review]. Frontiers in Medicine, 12, 1713424. doi: 10.3389/fmed.2025.1713424 Journal - Research Other
Highton, A., Kemp, R., & Dummer, J. (2025). Mini-lungs as an airway disease model platform. Proceedings of the Infectious Diseases & Pandemic Preparedness Summit. (pp. 45-46). Retrieved from https://www.teniwha.com Conference Contribution - Published proceedings: Abstract
Gaskarth, D. A., Fan, S., Highton, A. J., & Kemp, R. A. (2025). The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity. Frontiers in Medicine, 12, 1577906. doi: 10.3389/fmed.2025.1577906 Journal - Research Article
Ombasa, L., Miller, J., Ware, L., Abbotts-Holmes, H., Tang, J., Gasser, O., … Bayer, S., Kemp, R., Costello, R., Highton, A., … Schultz, M., Frampton, C., Gearry, R., … Roy, N. (2025). Impact of mānuka honey on symptoms and quality of life in individuals with functional dyspepsia: Protocol for a feasibility randomized controlled trial. JMIR Research Protocols, 14, e66417. doi: 10.2196/66417 Journal - Research Other
2026
Journal - Research Article
Longoni, A., Major, G. S., Arnold, S., Tomkins, S., Spessot, E., Loeffler, S., … Harte, J., Kemp, R., … Hooper, G. J., Woodfield, T. B. F., Kieser, D. C., & Lim, K. S. (2026). Characterization of an injectable poly(vinyl alcohol)-gelatin hydrogel for growth factor delivery in an orthopedic application. Advanced Healthcare Materials. Advance online publication. doi: 10.1002/adhm.202504224
2025
Journal - Research Article
Gaskarth, D. A., Fan, S., Highton, A. J., & Kemp, R. A. (2025). The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity. Frontiers in Medicine, 12, 1577906. doi: 10.3389/fmed.2025.1577906
Munoz-Erazo, L., Park, S. M., Lin, S., Chen, C.-J. J., Zhou, L. Y. Y., Rhodes, J. L., … McCall, J. L., Kemp, R. A., & Dunbar, P. R. (2025). A novel approach to digital characterisation of Tertiary Lymphoid Structures in colorectal cancer. Frontiers in Immunology, 16, 1500792. doi: 10.3389/fimmu.2025.1500792
Journal - Research Other
King, M. R., Kemp, R. A., & Gadeock, S. (2025). Type I interferons in inflammatory bowel diseases: Balancing barrier integrity, repair and inflammation in the intestinal epithelium [Mini review]. Frontiers in Medicine, 12, 1713424. doi: 10.3389/fmed.2025.1713424
Ombasa, L., Miller, J., Ware, L., Abbotts-Holmes, H., Tang, J., Gasser, O., … Bayer, S., Kemp, R., Costello, R., Highton, A., … Schultz, M., Frampton, C., Gearry, R., … Roy, N. (2025). Impact of mānuka honey on symptoms and quality of life in individuals with functional dyspepsia: Protocol for a feasibility randomized controlled trial. JMIR Research Protocols, 14, e66417. doi: 10.2196/66417
Kemp, R. A., & Marsh-Wakefield, F. (2025). Spatial immunology of tissue microenvironments. Frontiers in Immunology, 16, 1584850. doi: 10.3389/fimmu.2025.1584850
Borger, J. G., Longley, R. J., Taylor, M. F., Motrich, R., Payne, J. A. E., & Kemp, R. A. (2025). Global perspectives to enhance strategies for advancing women in healthcare and STEMM leadership. Immunology & Cell Biology, 103, 234-250. doi: 10.1111/imcb.12854
Conference Contribution - Published proceedings: Abstract
Highton, A., Kemp, R., & Dummer, J. (2025). Mini-lungs as an airway disease model platform. Proceedings of the Infectious Diseases & Pandemic Preparedness Summit. (pp. 45-46). Retrieved from https://www.teniwha.com
Shafaei Pishabad, Z., Sarkar, D., Jeffs, A., Samaratunga, H., Rhodes, J., Costello, R., Highton, A., Wright, D., Pattison, S., Kemp, R., Delahunt, B., Braithwaite, A., Slatter, T., & Mehta, S. (2025). Development of a prognostic tool for identifying high-risk prostate cancer patients. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go
2024
Authored Book - Research
Kemp, R. A., & Brown, D. M. (2024). How to be a scientist: Critical thinking in the life sciences. Boca Raton, FL: CRC Press, 252p. doi: 10.1201/9781003326366
Conference Contribution - Published proceedings: Abstract
Costello, R. M., Fenton, S., McGuire, H., Lim, L., Howell, D., Raza, Q., … Kemp, R. (2024). Predicting colorectal patient prognoses by functional characterisation of heterogeneous cell types and their spatial interaction using a new technique: Whole slide imaging mass cytometry. Cancer Research, 84(6, Suppl.), 67. doi: 10.1158/1538-7445.AM2024-67
Conference Contribution - Verbal presentation and other Conference outputs
Roy, A., Highton, A., Laws, G., Schultz, M., & Kemp, R. (2024, August). Investigating immune-bacteria interactions through organoid-derived monolayer models from Crohn’s disease patients. Verbal presentation at the BMS Postgraduate Symposium, Dunedin, New Zealand.
Devery, B. G. J., Ward-Hartstonge, K. A., Paringatai, K., & Kemp, R. A. (2024, August). Making the jigsaw fit, intertwining immunology and mātauranga Māori to pursue research equity in cancer research. Verbal presentation at the BMS Postgraduate Symposium, Dunedin, New Zealand.
King, M., Highton, A., Fan, L., Schultz, M., Kemp, R., & Gadeock, S. (2024, August). The role of type I interferons in regulating epithelial barrier integrity in human 3D stem cell derived organoids. Verbal presentation at the BMS Postgraduate Symposium, Dunedin, New Zealand.
2023
Journal - Research Article
Norton, S. E., Khong, T., Ramachandran, M., Highton, A. J., Ward-Hartstonge, K. A., Shortt, J. S., … Kemp, R. A. (2023). Changes in immune cell populations following KappaMab, lenalidomide and low-dose dexamethasone treatment in multiple myeloma. Clinical & Translational Immunology, 12, e1478. doi: 10.1002/cti2.1478
Major, G., Longoni, A., Simcock, J., Magon, N. J., Harte, J., Bathish, B., Kemp, R., Woodfield, T., & Lim, K. S. (2023). Clinical applicability of visible light-mediated cross-linking for structural soft tissue reconstruction. Advanced Science, 10, 2300538. doi: 10.1002/advs.202300538
2022
Journal - Research Article
Angus, H. C. K., Urbano, P. C. M., Laws, G. A., Fan, S., Gadeock, S., Schultz, M., … Highton, A. J., & Kemp, R. A. (2022). An autologous colonic organoid-derived monolayer model to study immune: bacterial interactions in Crohn's disease patients. Clinical & Translational Immunology, 11, e1407. doi: 10.1002/cti2.1407
Naqash, A., Stuart, G., Kemp, R., & Wise, L. (2022). Parapoxvirus interleukin-10 homologues vary in their receptor binding, anti-inflammatory, and stimulatory activities. Pathogens, 11, 507. doi: 10.3390/pathogens11050507
Urbano, P. C. M., Angus, H. C. K., Gadeock, S., Schultz, M., & Kemp, R. A. (2022). Assessment of source material for human intestinal organoid culture for research and clinical use. BMC Research Notes, 15, 35. doi: 10.1186/s13104-022-05925-4
Kalff, A., Khong, T., Ramachandran, M., Ho, P. J., Mollee, P., D'Rozario, J., … Norton, S., Kemp, R., … Spencer, A. (2022). Planned withdrawal of dexamethasone after pomalidomide low dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14). Haematologica, 107(1), 321-325. doi: 10.3324/haematol.2021.278655
Conference Contribution - Published proceedings: Abstract
Highton, A., Urbano, P., Fan, L., Laws, G., Schultz, M., & Kemp, R. (2022). Predicting anti-TNF responses in inflammatory bowel disease patients using intestinal organoids. Proceedings of the New Zealand Branch of the Australian and New Zealand Society for Immunology (NZASI) Conference. (pp. 34). Retrieved from https://nzasi2022.com/programme
Laws, G., Angus, H., Fan, L., Urbano, P., Highton, A., Schultz, M., & Kemp, R. (2022). Inflammatory T cells result in epithelial damage in patients with Crohn's disease. Proceedings of the New Zealand Branch of the Australian and New Zealand Society for Immunology (NZASI) Conference. (pp. 26). Retrieved from https://nzasi2022.com/programme
Gaskarth, D., Niemi, G., Morgan, X., & Kemp, R. (2022). Short-chain fatty-acids: Boosting the anti-tumour function of CD8+ T cells. Proceedings of the New Zealand Branch of the Australian and New Zealand Society for Immunology (NZASI) Conference. (pp. 21). Retrieved from https://nzasi2022.com/programme
Costello, R., Rhodes, J., Miller, M., Munro, F., Kemp, R., & Slatter, T. (2022). Association of cancer-associated fibroblast phenotype and frequency with two-point immunoscore in colorectal cancer patients. Proceedings of the New Zealand Branch of the Australian and New Zealand Society for Immunology (NZASI) Conference. (pp. 11). Retrieved from https://nzasi2022.com/programme
Other Research Output
Kemp, R. (2022, October). Some T cells are more equal than others. University of Otago, Dunedin, New Zealand. [Inaugural Professorial Lecture].
2021
Journal - Research Article
Hazlett, J., Niemi, V., Aiderus, A., Powell, K., Wise, L., Kemp, R., & Dunbier, A. K. (2021). Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer. Breast Cancer Research, 23, 95. doi: 10.1186/s13058-021-01472-1
Naciute, M., Kiwitt, T., Kemp, R. A., & Hook, S. (2021). Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration. Vaccine, 39, 5589-5599. doi: 10.1016/j.vaccine.2021.08.028
Laws, G. A., Hale, J. D. F., & Kemp, R. A. (2021). Human systemic immune response to ingestion of the oral probiotic Streptococcus salivarius BLIS K12. Probiotics & Antimicrobial Proteins, 13, 1521-1529. doi: 10.1007/s12602-021-09822-3
Journal - Research Other
Marsh-Wakefield, F. M. D., Mitchell, A. J., Norton, S. E., Ashurst, T. M., Leman, J. K. H., Roberts, J. M., Harte, J. E., … Kemp, R. A. (2021). Making the most of high-dimensional cytometry data. Immunology & Cell Biology, 99, 680-696. doi: 10.1111/imcb.12456
Conference Contribution - Published proceedings: Abstract
Tabi-Amponsah, A. D., Stuart, G. S., Kemp, R. A., & Wise, L. M. (2021). Dissecting the receptor signalling events responsible for the immune suppressive and immune stimulatory effects of IL-10. New Zealand Medical Journal, 134(1547), (pp. 144). Retrieved from https://www.nzma.org.nz/journal
Naqash, A., Kemp, R., Glass, M., & Wise, L. (2021). Control of immune cell function by IL-10 proteins derived from viruses. Proceedings of the University of Otago Student Research Symposium: Te Wānaka Rakahau: Ākoka. (pp. 46). [Abstract]
Harte, J., Leman, J., Munro, F., McCall, J., McGuire, H., & Kemp, R. (2021). Inhibitory receptor expressing T cells produce functional cytokines and are enriched in the tumour compared to the non-tumour bowel and peripheral blood of patients with colorectal cancer. New Zealand Medical Journal, 134(1537), (pp. 111). Retrieved from https://www.nzma.org.nz/journal
Conference Contribution - Verbal presentation and other Conference outputs
Kemp, R. (2021, July). Why do scientists discount evidence that addresses gender equity? Verbal presentation at the Association for Women in the Sciences (AWIS) Triennial Conference: Embracing Diversity, Dunedin, New Zealand.
2020
Chapter in Book - Research
Leman, J. K. H., Munoz-Erazo, L., & Kemp, R. A. (2020). The intestinal tumour microenvironment. In A. Birbrair (Ed.), Tumor microenvironments in organs: From the brain to the skin: Part A. (pp. 1-22). Cham, Switzerland: Springer. doi: 10.1007/978-3-030-36214-0_1
Journal - Research Article
Niemi, V., Gaskarth, D., & Kemp, R. A. (2020). Extensive variability in the composition of immune infiltrate in different mouse models of cancer. Laboratory Animal Research, 36, 43. doi: 10.1186/s42826-020-00075-9
Naciute, M., Niemi, V., Kemp, R. A., & Hook, S. (2020). Lipid-encapsulated oral therapeutic peptide vaccines reduce tumour growth in an orthotopic mouse model of colorectal cancer. European Journal of Pharmaceutics & Biopharmaceutics, 153, 183-192. doi: 10.1016/j.ejpb.2020.04.020
Journal - Research Other
Munoz-Erazo, L., Rhodes, J. L., Marion, V. C., & Kemp, R. A. (2020). Tertiary lymphoid structures in cancer: Considerations for patient prognosis. Cellular & Molecular Immunology, 17, 570-575. doi: 10.1038/s41423-020-0457-0
Norton, S. E., Leman, J. K. H., Khong, T., Spencer, A., Fazekas de St Groth, B., McGuire, H. M., & Kemp, R. A. (2020). Brick plots: An intuitive platform for visualizing multiparametric immunophenotyped cell clusters. BMC Bioinformatics, 21, 145. doi: 10.1186/s12859-020-3469-y
Angus, H. C. K., Butt, A. G., Schultz, M., & Kemp, R. A. (2020). Intestinal organoids as a tool for inflammatory bowel disease research. Frontiers in Medicine, 6, 334. doi: 10.3389/fmed.2019.00334
Conference Contribution - Published proceedings: Abstract
Dunbier, A. K., Hazlett, J. A., Powell, K., Niemi, G., & Kemp, R. (2020). Investigation of combination treatment an aromatase inhibitor and anti-inflammatory treatment in a model of oestrogen receptor positive breast cancer. Cancer Research, 80(4, Suppl.), P1-03-07. doi: 10.1158/1538-7445.Sabcs19-p1-03-07
Kemp, R., Angus, H., Butt, G., & Schultz, M. (2020). Understanding human Crohn's disease: T cell immunoprofiling and in vitro primary intestinal epithelial monolayer models. Journal of Immunology, 204(1, Suppl.), 224.4. [Abstract]
2019
Chapter in Book - Research
Norton, S., & Kemp, R. (2019). Computational analysis of high-dimensional mass cytometry data from clinical tissue samples. In H. M. McGuire & T. M. Ashhurst (Eds.), Mass cytometry: Methods and protocols: Methods in molecular biology (Vol. 1989). (pp. 295-308). New York, NY: Humana Press. doi: 10.1007/978-1-4939-9454-0_19
Journal - Research Article
Norton, S. E., Ward-Hartstonge, K. A., McCall, J. L., Leman, J. K. H., Taylor, E. S., Munro, F., Black, M. A., … Kemp, R. A. (2019). High-dimensional mass cytometric analysis reveals an increase in effector regulatory T cells as a distinguishing feature of colorectal tumors. Journal of Immunology, 202, 1871-1884. doi: 10.4049/jimmunol.1801368
Lepletier, A., Lutzky, V. P., Mittal, D., Stannard, K., Watkins, T. S., Ratnatunga, C. N., … Kemp, R. A., … Miles, J. J. (2019). The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor-infiltrating T cells. Immunology & Cell Biology, 97, 152-164. doi: 10.1111/imcb.12205
Journal - Research Other
Laws, G. A., & Kemp, R. A. (2019). Probiotics and health: Understanding probiotic trials. New Zealand Medical Journal, 132(1498), 90-96. Retrieved from https://www.nzma.org.nz/journal
Sarfati, D., Jackson, C. G. C. A., Macfarlane, S., Bissett, I., Robson, B., Gurney, J., Kemp, R., … McMenamin, J. (2019). Cancer Care at a Crossroads: Time to make a choice. New Zealand Medical Journal, 132(1493), 6-11. Retrieved from https://www.nzma.org.nz/journal
2018
Journal - Research Article
Leman, J. K. H., Sandford, S. K., Rhodes, J. L., & Kemp, R. A. (2018). Multiparametric analysis of colorectal cancer immune responses. World Journal of Gastroenterology, 24(27), 2995-3005. doi: 10.3748/wjg.v24.i27.2995
Taylor, E. S., McCall, J. L., Shen, S., Girardin, A., Munro, F. M., Black, M. A., Ward-Hartstonge, K. A., & Kemp, R. A. (2018). Prognostic roles for IL-2-producing and CD69+ T cell subsets in colorectal cancer patients. International Journal of Cancer, 143(8), 2008-2016. doi: 10.1002/ijc.31598
Conference Contribution - Published proceedings: Abstract
Moloney-Geany, K., Norton, S., Ward-Hartstonge, K., Munro, F., McCall, J., & Kemp, R. (2018). Suppression of effector T cell function in colorectal cancer. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Rhodes, J., McCall, J., Pattison, S., Ward-Hartstonge, K., Sandford, S., Munro, F., Black, M., & Kemp, R. (2018). Refining multiplex immunohistochemistry to quantify in situ immune infiltrate: Improving survival of colorectal cancer patients. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Naciute, M., Niemi, G., Gibson, B., Kemp, R., & Hook, S. (2018). Oral therapeutic vaccination against colorectal cancer. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Hazlett, J., Niemi, G., Kemp, R., & Dunbier, A. (2018). Investigation of combination treatment an aromatase inhibitor and anti-inflammatory treatment in a model of oestrogen receptor positive breast cancer. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Harte, J., Niemi, G., Hook, S., & Kemp, R. (2018). Detection of AH1 antigen specific T cells in a murine colorectal cancer model. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Gaskarth, D., Niemi, G., Highton, A., Hook, S., & Kemp, R. (2018). Characterising T cell response in an orthotopic intracaecal mouse model of colorectal cancer. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Leman, J., McCall, J., Ward-Hartstonge, K., Norton, S., Munro, F., McGuire, H., & Kemp, R. (2018). Characterising dysfunctional T cells in colorectal cancer. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Norton, S., Ward-Hartstonge, K., McCall, J., Leman, J., Shen, S., Taylor, E., Munro, F., Black, M., … Kemp, R. (2018). An increase in effector Tregs is a classifying feature of the immune landscape in colorectal tumours. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Niemi, G. R., Highton, A. J., Hook, S. M., & Kemp, R. A. (2018). Modulating the immune response to colorectal cancer in mice using a cancer vaccine. New Zealand Medical Journal, 131(1470), (pp. 111). Retrieved from https://www.nzma.org.nz/journal
Conference Contribution - Verbal presentation and other Conference outputs
Gaskarth, D. A., Niemi, G. R., Highton, A., Hook, S., & Kemp, R. A. (2018, August). Characterising T cell responses in an orthotopic intracaecal mouse model of colorectal cancer. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
Niemi, G. R., Naciute, M., Cockerill, S., & Kemp, R. A. (2018, August). Immunologic considerations of a surgical mouse model of colorectal cancer. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
Laws, G., Hale, J., McConnell, M., & Kemp, R. (2018, August). The effect of the probiotic Streptococcus salivarious (BLIS) K12 on human systemic immune responses. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
Shirley, S., Kemp, R., Cakebread, J., & Hodgkinson, A. (2018, August). Is the immune system of naïve mice affected by cow's milk? Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
Angus, H. C. K., Aluzaite, K., Butt, G. A., Schultz, M., & Kemp, R. A. (2018, August). Novel investigation of Crohn's disease T cell phenotypes and functionality in an in vitro human colonoid model. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
Rhodes, J. L., McCall, J. L., Pattison, S. T., Ward-Hartstonge, K. A., Sandford, S. K., Munro, F. M., Black, M. A., & Kemp, R. A. (2018, August). Refining multiplex immunohistochemistry to quantify in situ immune infiltrate: Improving survival of colorectal cancer patients. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
Hazlett, J., Niemi, G., Kemp, R., & Dunbier, A. (2018, August). Investigation of combination treatment of an aromatase inhibitor and anti-inflammatory treatment in a model of oestrogen receptor positive breast cancer. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
Naciute, M., Niemi, G., Gibson, B., Kemp, R., & Hook, S. (2018, August). Immune response to oral therapeutic vaccination against colorectal cancer. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
Leman, J., McCall, J., Ward-Hartstonge, K. A., Norton, S., Munro, F., McGuire, H., & Kemp, R. A. (2018, August). Characterising dysfunctional T cells in colorectal cancer. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
Other Research Output
Kemp, R. (2018, July). Vision Mātauranga/Responsiveness to Māori statements. Department of Biochemistry, and Department of Microbiology & Immunology, University of Otago, Dunedin, New Zealand. [Department Seminar].
2017
Journal - Research Article
Ward-Hartstonge, K. A., McCall, J. L., McCulloch, T. R., Kamps, A.-K., Girardin, A., Cretney, E., Munro, F. M., & Kemp, R. A. (2017). Inclusion of BLIMP-1+ effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: A pilot study. Cancer Immunology, Immunotherapy, 66(4), 515-522. doi: 10.1007/s00262-016-1951-1
Journal - Research Other
Ward-Hartstonge, K. A., & Kemp, R. A. (2017). Regulatory T-cell heterogeneity and the cancer immune response. Clinical & Translational Immunology, 6, e154. doi: 10.1038/cti.2017.43
Conference Contribution - Published proceedings: Abstract
Kemp, R. (2017). Immunology in cancer: Using big data to improve outcomes. New Zealand Dental Journal, 113(4), (pp. 52). [Abstract]
Angus, H., Norton, S., Dunn, E., Aluzaite, K., Gadeock, S., Butt, G., & Kemp, R. (2017). Development of in vitro models for human Crohn's disease. Proceedings of the University of Otago Student Research Symposium: Te Wānaka Rakahau: Ākoka. (pp. 4). Retrieved from http://www.otago.ac.nz/graduate-research/scholarships/otago643219.html
Niemi, G., Hook, S., & Kemp, R. (2017). Comparison of immune cell infiltrate between subcutaneous melanoma and colon carcinoma mouse models. Proceedings of the University of Otago Student Research Symposium: Te Wānaka Rakahau: Ākoka. (pp. 62-63). Retrieved from http://www.otago.ac.nz/graduate-research/scholarships/otago643219.html
Hazlett, J., Hunter, B., Kemp, R., & Dunbier, A. (2017). Investigating immune responsiveness in oestrogen receptor positive breast cancer. In A. Blackman, L. Gillman, C. Oliver & D. Dantzic (Eds.), Proceedings of the Inaugural New Zealand Breast Cancer Symposium (NZBCS): United for a Cure through Research. (pp. 52). Auckland, New Zealand: Auckland University of Technology. [Abstract]
Niemi, G., Naciute, M., Highton, A., Gibson, B., Hook, S., & Kemp, R. (2017). Altering the immune response to colorectal cancer in mouse models. Proceedings of the 46th Australasian Society for Immunology (ASI) Annual Scientific Meeting. 341. Retrieved from http://www.asi2017.org/
Niemi, V. R., Highton, A. J., Hook, S. M., & Kemp, R. A. (2017). Comparison of immune cell infiltrate between subcutaneous melanoma and colon carcinoma mouse models. New Zealand Medical Journal, 130(1452), (pp. 78). Retrieved from https://www.nzma.org.nz/journal
Conference Contribution - Verbal presentation and other Conference outputs
Kemp, R. (2017, October). Infiltrating immune cells that predict patient outcome. Invited presentation at the New Zealand Society for Oncology (NZSO) Conference, Auckland, New Zealand.
Angus, H., Aluzaite, K., Schultz, M., Butt, G., & Kemp, R. (2017, July). Investigation into T cell-mediated Crohn's disease. Verbal presentation at the New Zealand Branch of the Australasian Society for Immunology (NZ ASI) Annual Scientific Meeting, Christchurch, New Zealand.
Ward Hartstonge, K. A., McCall, J. L., Kamps, A.-K., McCulloch, T., Cretney, E., Munro, F., & Kemp, R. A. (2017, July). Blimp-1+ IL-10-producing regulatory T cells are associated with longer disease-free survival in colorectal cancer. Verbal presentation at the New Zealand Branch of the Australasian Society for Immunology (NZ ASI) Annual Scientific Meeting, Christchurch, New Zealand.
Kennedy, B. R., McCall, J. L., Miller, A. P., Gibbs, D. D., Kemp, R. A., & Currie, M. J. (2017, July). Identifying neutrophil subpopulations in colorectal cancer. Verbal presentation at the New Zealand Branch of the Australasian Society for Immunology (NZ ASI) Annual Scientific Meeting, Christchurch, New Zealand.
Shirley, S., Kemp, R., Hodgkinson, A., & Cakebread, J. (2017, July). Are immune responses in mice affected by cow's milk? Verbal presentation at the New Zealand Branch of the Australasian Society for Immunology (NZ ASI) Annual Scientific Meeting, Christchurch, New Zealand.
Dunbier, A., Hazlett, J., Wise, L., & Kemp, R. (2017, July). Effect of oestrogen deprivation on chemokine expression and immune cell recruitment in breast cancer. Verbal presentation at the New Zealand Branch of the Australasian Society for Immunology (NZ ASI) Annual Scientific Meeting, Christchurch, New Zealand.
2016
Journal - Research Article
Neumann, S., Shirley, S. A., Kemp, R. A., & Hook, S. M. (2016). Improved antitumor activity of a therapeutic melanoma vaccine through the use of the dual COX-2/5-LO inhibitor licofelone. Frontiers in Immunology, 7(537), 537. doi: 10.3389/fimmu.2016.00537
Highton, A. J., Girardin, A., Bell, G. M., Hook, S. M., & Kemp, R. A. (2016). Chitosan gel vaccine protects against tumour growth in an intracaecal mouse model of cancer by modulating systemic immune responses. BMC Immunology, 17, 39. doi: 10.1186/s12865-016-0178-4
Taylor, E. S., McCall, J. L., Girardin, A., Munro, F. M., Black, M. A., & Kemp, R. A. (2016). Functional impairment of infiltrating T cells in human colorectal cancer. OncoImmunology, 5(11), e1234573. doi: 10.1080/2162402X.2016.1234573
Parayath, N. N., Nehoff, H., Norton, S. E., Highton, A. J., Taurin, S., Kemp, R. A., & Greish, K. (2016). Styrene maleic acid-encapsulated paclitaxel micelles: Antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model. International Journal of Nanomedicine, 11, 3979-3991. doi: 10.2147/IJN.S110251
Dunn, E. T. J., Taylor, E. S., Stebbings, S., Schultz, M., Butt, A. G., & Kemp, R. A. (2016). Distinct immune signatures in the colon of Crohn's disease and ankylosing spondylitis patients in the absence of inflammation. Immunology & Cell Biology, 94(5), 421-429. doi: 10.1038/icb.2015.112
Norton, S. E., Dunn, E. T. J., McCall, J. L., Munro, F., & Kemp, R. A. (2016). Gut macrophage phenotype is dependent on the tumor microenvironment in colorectal cancer. Clinical & Translational Immunology, 5(4), e76. doi: 10.1038/cti.2016.21
Conference Contribution - Published proceedings: Abstract
Kemp, R., Ward Hartstonge, K. A., McCulloch, T., Kamps, A.-K., Cretney, E., & McCall, J. (2016). Infiltrate of effector regulatory T cells predicts outcome in a cohort of New Zealand colorectal cancer patients: A pilot study. Journal of Immunology, 196(1, Suppl. ), 212.3. [Abstract]
Norton, S., Taylor, E., Dunn, E., Munro, F., Black, M., McCall, J., & Kemp, R. (2016). Tumours from patients with colorectal cancer may dysregulate gut macrophage function and phenotype. European Journal of Immunology, 46(Suppl. 1), (pp. 439). doi: 10.1002/eji.201670200
Shen, S., Taylor, E., Ward-Hartstonge, K., McCall, J., & Kemp, R. (2016). Impaired signalling in T cells from patients with colorectal cancer in response to IL-2 and IL-7. European Journal of Immunology, 46(Suppl. 1), (pp. 231). doi: 10.1002/eji.201670200
Highton, A., Niemi, V., Hook, S., & Kemp, R. (2016). Chitosan hydrogel vaccine generates CD8+ T cell memory protective in a mouse tumour model of colorectal cancer. European Journal of Immunology, 46(Suppl. 1), (pp. 201). doi: 10.1002/eji.201670200
Ward Hartstonge, K., McCulloch, T., Kamps, A., Cretney, E., Munro, F., McCall, J., & Kemp, R. (2016). Effector regulatory T cells are associated with disease-free survival in colorectal cancer. European Journal of Immunology, 46(Suppl. 1), (pp. 35-36). doi: 10.1002/eji.201670200
Shen, S., Taylor, E. S., Munro, F., McCall, J. L., Ward-Hartstonge, K. A., & Kemp, R. A. (2016). Determining the role of tumour infiltrating IL-2 producing T cells in patients with colorectal cancer. New Zealand Medical Journal, 129(1441), (pp. 109). Retrieved from http://www.nzma.org.nz/journal
2015
Chapter in Book - Research
Highton, A. J., & Kemp, R. A. (2015). Immunological background. In C. Foged, T. Rades, Y. Perrie & S. Hook (Eds.), Subunit vaccine delivery. (pp. 3-14). New York: Springer. doi: 10.1007/978-1-4939-1417-3
Journal - Research Article
Norton, S. E., Ward-Hartstonge, K. A., Taylor, E. S., & Kemp, R. A. (2015). Immune cell interplay in colorectal cancer prognosis. World Journal of Gastrointestinal Oncology, 7(10), 221-232. doi: 10.4251/wjgo.v7.i10.221
Highton, A. J., Kojarunchitt, T., Girardin, A., Hook, S., & Kemp, R. A. (2015). Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma. Immunology & Cell Biology, 93, 634-640. doi: 10.1038/icb.2015.14
Conference Contribution - Published proceedings: Abstract
Parayath, N. N., Norton, S., Taurin, S., Kemp, R., & Greish, K. (2015). Styrene maleic acid micelles as a nanocarrier system for oral delivery of paclitaxel. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting: Drugs to Medicines: Up Close and Personal. 240. Retrieved from http://www.asceptasm.com/
Kemp, R., Norton, S., Taylor, E., Dunn, E., Munro, F., Black, M., & McCall, J. (2015). Colorectal tumour associated macrophages are more pro-inflammatory than adjacent control bowel tissue macrophage populations. Journal of Immunology, 194(1, Suppl.), TUM6P.1003. [Abstract]
Conference Contribution - Poster Presentation (not in published proceedings)
Ward-Hartstonge, K., McCulloch, T., Cretney, E., Munro, F., McCall, J., & Kemp, R. (2015, August-September). Analysis of specific T cell infiltrate can predict patient prognosis in a NZ cohort of colorectal cancer patients. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Thomson, K., Kemp, R., Brooks, H., & McConnell, M. (2015, November). Probiotic bacteria reduce the pro-inflammatory response by enterocytes in response to bacteria isolated from cases of necrotizing enterocolitis. Verbal presentation at the Toxicology Symposium: Toxicology for the Modern Researcher, Dunedin, New Zealand.
Dunbier, A. K., Hazlett, J. A., Hunter, B. L., Buchanan, S. T., Bundock, A. S., Wise, L. M., Kemp, R. A., & Dowsett, M. (2015, August-September). Determinants of resistance to endocrine therapy in breast cancer. Verbal presentation at the Medical Sciences Congress (MedSci), Queenstown, New Zealand.
Kemp, R. (2015, August-September). Using the complex immune response in colorectal cancer to predict patient outcome. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2014
Journal - Research Article
Neumann, S., Burkert, K., Kemp, R., Rades, T., Dunbar, P. R., & Hook, S. (2014). Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants. Immunology & Cell Biology, 92, 535-542. doi: 10.1038/icb.2014.21
Conference Contribution - Published proceedings: Abstract
Ward-Hartstonge, K., Taha, A., Hung, N., Kemp, R., & Slatter, T. (2014). Increased CD163 expression defines a subgroup of glioblastoma multiforme. New Zealand Medical Journal, 127(1395). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Poster Presentation (not in published proceedings)
Ward Hartstonge, K., Taylor, E., Slatter, T., McCulloch, T., Cretney, E., & Kemp, R. (2014, November). The characterisation and role of effector regulatory T cells in colorectal cancer. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Shirley, S., Hook, S., Kemp, R., & Neumann, S. (2014, November). MDSC and their potential role in therapeutic vaccine formulations. Poster session presented at the Devices for Diagnostics and Drug Delivery (D4) Conference, Dunedin, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Kemp, R. (2014, August). The balance of immune populations in colorectal cancer: A new target for immunotherapy. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2013
Journal - Research Article
Schultz, M., Dunn, E., Taylor, E., Butt, G. A., & Kemp, R. (2013). The Gut Map Project: T cell distribution in inflammation of the gut. Journal of Gastroenterology & Hepatology, 28(Suppl. 3), 588. doi: 10.1111/jgh.12363_2
Kemp, R., Dunn, E., & Schultz, M. (2013). Immunomodulators in inflammatory bowel disease: An emerging role for biologic agents. BioDrugs, 27(6), 585-590. doi: 10.1007/s40259-013-0045-2
Girardin, A., McCall, J., Black, M. A., Edwards, F., Phillips, V., Taylor, E. S., Reeve, A. E., & Kemp, R. A. (2013). Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients. International Journal of Cancer, 132(8), 1842-1850. doi: 10.1002/ijc.27855
Conference Contribution - Published proceedings: Abstract
Kemp, R., Taylor, E., Girardin, A., Munro, F., Black, M., & McCall, J. (2013). Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients. Journal of Immunology, 190(1, Suppl.), 170.29. [Abstract]
Neumann, S., Kemp, R., Dunbar, R., Rades, T., & Hook, S. (2013). Activation of the NLRP3 inflammasome through chitosan nanoparticles and subsequent cytokine production leads to the generation of CD11b+ Gr-1+ myeloid derived suppressor cells. Proceedings of the 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT). (pp. 178). Retrieved from http://www.cimt.eu/meetings/archive
Thomson, K., Kemp, R., & McConnell, M. (2013). Probiotic bacteria influence IL-8 production by HT-29 enterocytes in response to enterobacteriaceae. Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 166-167). Retrieved from http://www.asi2013.org/
Neumann, S., Young, K., Kemp, R., Painter, G., Dunbar, R., & Hook, S. (2013). Investigating cytotoxic T cell responses to long peptide vaccine formulations. Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 158). Retrieved from http://www.asi2013.org/
Highton, A., Hook, S., & Kemp, R. (2013). Immunisation using a sustained release vaccine generates functional CD8 T cell memory. Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 156-157). Retrieved from http://www.asi2013.org/
Ward-Hartstonge, K., Taylor, E., Cretney, E., Slatter, T., & Kemp, R. (2013). Effector regulatory T cells in colorectal cancer. Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 142). Retrieved from http://www.asi2013.org/
Bell, G., Budhwani, M., Highton, A., Hibma, M., & Kemp, R. (2013). Construction of a melanoma cell line for orthotopic models of cancer. Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 132). Retrieved from http://www.asi2013.org/
Taylor, E., Girardin, A., Dunn, E., Munro, F., Black, M., McCall, J., & Kemp, R. (2013). Analysis of T cell subsets in colorectal cancer patients. Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 102). Retrieved from http://www.asi2013.org/
Dunn, E., Taylor, E., Schultz, M., Butt, G., & Kemp, R. (2013). Macrophage and T cell distribution in autoimmune inflammation of the gut. Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 86). Retrieved from http://www.asi2013.org/
Dunn, E., Taylor, E., Stebbings, S., Schultz, M., Butt, G., & Kemp, R. (2013). T cell distribution in gastrointestinal inflammatory disorders. New Zealand Medical Journal, 126(1387). Retrieved from http://www.nzma.org.nz/journal
Norton, S., Dunn, E., Munro, F., McCall, J., & Kemp, R. (2013). Phenotypic and functional characterisation of human macrophages: A role in colorectal cancer. New Zealand Medical Journal, 126(1386). Retrieved from http://www.nzma.org.nz/journal
Dunn, E., Kemp, R., Schultz, M., & Butt, G. (2013). Long-term in vitro expansion of human intestinal organoids. New Zealand Medical Journal, 126(1374). Retrieved from http://www.nzma.org.nz/journal
Neumann, S., Kemp, R., Rades, T., Dunbar, R., & Hook, S. (2013). Evaluating adjuvant characteristics of particulate formulations. Proceedings of 15th Conference on Formulation and Delivery of Bioactives: Found in Translation. Retrieved from http://bioactives.otago.ac.nz/
Conference Contribution - Poster Presentation (not in published proceedings)
Dunn, E., Taylor, E., Schultz, M., Butt, G., & Kemp, R. (2013, September). Macrophage and T cell distribution in autoimmune inflammation of the gut. Poster session presented at the Division of Health Sciences Research Forum: Foundations for Health: Otago Health Research, Christchurch, New Zealand.
2012
Journal - Research Article
Gordon, S., Young, K., Wilson, R., Rizwan, S., Kemp, R., Rades, T., & Hook, S. (2012). Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems. Journal of Liposome Research, 22(3), 193-204. doi: 10.3109/08982104.2011.637502
Conference Contribution - Published proceedings: Abstract
Dunn, E., Taylor, E., Schultz, M., Butt, G., & Kemp, R. (2012). Macrophage and T cell distribution in autoimmune inflammation of the gut. New Zealand Medical Journal, 125(1367). Retrieved from http://www.nzma.org.nz/journal
Highton, A., Girardin, A., Hook, S., & Kemp, R. (2012). Immunisation using a sustained release vaccine generates CD8 T cell memory population in the gut. New Zealand Medical Journal, 125(1364). Retrieved from http://www.nzma.org.nz/journal
Highton, A., Girardin, A., Hook, S. M., & Kemp, R. A. (2012). Immunisation using sustained release vaccines generates a discrete CD8 T cell memory population in the gut. Proceedings of the New Zealand Chapter of the Controlled Release Society 14th Conference on Formulation and Delivery of Bioactives. Retrieved from http://bioactives.otago.ac.nz/
Conference Contribution - Poster Presentation (not in published proceedings)
Highton, A. J., Girardin, A., Hook, S. M., & Kemp, R. A. (2012, September). Immunisation using sustained release vaccines generates a discrete CD8T cell memory population in the gut. Poster session presented at the Division of Health Sciences Research Forum: Health Matters: Research Excellence at Otago, Dunedin, New Zealand.
Taylor, E., Girardin, A., Dunn, E., Munro, F., Black, M., McCall, J., & Kemp, R. (2012, September). T cell subset analysis in human colorectal cancer patients. Poster session presented at the Division of Health Sciences Research Forum: Health Matters: Research Excellence at Otago, Dunedin, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Kemp, R., Day, A., Nolan, A., Tannock, G., & Gearry, R. (2012, June). Who are we (Part I). Panel discussion at the Inaugural GutHealth Network Workshop, Dunedin, New Zealand.
2011
Journal - Research Article
Kemp, R. A., Black, M. A., McCall, J., Yoon, H.-S., Phillips, V., Anjomshoaa, A., & Reeve, A. E. (2011). T cell subpopulations in lymph nodes may not be predictive of patient outcome in colorectal cancer. Journal of Experimental & Clinical Cancer Research, 30, 78. doi: 10.1186/1756-9966-30-78
Conference Contribution - Poster Presentation (not in published proceedings)
Highton, A. J., Girardin, A., Hook, S. M., & Kemp, R. A. (2011, December). Immunisation using sustained release vaccines generates a discrete CD8 T cell memory population in the gut. Poster session presented at the 41st Australasian Society for Immunology (ASI) Annual Meeting, Adelaide, Australia.
Conference Contribution - Verbal presentation and other Conference outputs
Kemp, R. (2011, February). Characterising immunological needs of patients. Invited presentation at the New Zealand Chapter of the Controlled Release Society 13th Conference on Formulation and Delivery of Bioactives, Dunedin, New Zealand.
2010
Journal - Research Article
Ting, Y. T., Coates, T. P., Marti, H. P., Dunn, A. C., Parker, R. M., Pickering, J. W., Jack, R. W., Kemp, R. A., Walker, R. J., & McLellan, A. D. (2010). Urinary soluble HLA-DR is a potential biomarker for acute renal transplant rejection. Transplantation, 89(9), 1071-1078. doi: 10.1097/TP.0b013e3181d15492
Kemp, R. A., Pearson, C. F., Cornish, G. H., & Seddon, B. P. (2010). Evidence of STAT5-dependent and -independent routes to CD8 memory formation and a preferential role for IL-7 over IL-15 in STAT5 activation. Immunology & Cell Biology, 88, 213-219. doi: 10.1038/icb.2009.95
Bouwer, A. L., Netter, P., Kemp, R. A., & McLellan, A. D. (2010). A defined serum-free medium useful for monitoring anti-melanoma responses induced by dendritic cell immunotherapy. Journal of Immunological Methods, 352, 178-181. doi: 10.1016/j.jim.2009.11.001
Conference Contribution - Published proceedings: Abstract
Highton, A., Girardin, A., Hook, S., & Kemp, R. (2010). Site-specific memory T cells generated from sustained antigen-release vaccination. New Zealand Medical Journal. 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4493/content.pdf
Prier, J., Girardin, A., & Kemp, R. (2010). Differential requirements for T cell receptor and gamma chain cytokine receptors in naïve and memory T cells. New Zealand Medical Journal. 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4493/content.pdf
Prier, J., Girardin, A., & Kemp, R. (2010). Disrupting cell metabolism to enhance memory responses to vaccination. New Zealand Medical Journal, 123(1314). Retrieved from http://journal.nzma.org.nz/journal/123-1314/4120/content.pdf
Conference Contribution - Poster Presentation (not in published proceedings)
Kemp, R., Girardin, A., Yoon, H.-S., Phillips, V., Anjomshoaa, A., & Reeve, A. (2010, August). The presence of Foxp3+ T cells in the lymph node as an indicator of patient outcome in colorectal cancer. Poster session presented at the 14th International Congress of Immunology, Kobe, Japan.
Conference Contribution - Verbal presentation and other Conference outputs
Prier, J. E., Girardin, A. T., & Kemp, R. A. (2010, July). Disrupting cell metabolism enhances CD8 T cell memory responses to vaccination. Verbal presentation at the New Zealand Australasian Society for Immunology (NZ ASI) Branch Meeting, Wellington, New Zealand.
Girardin, A., Hook, S. M., Kemp, R. A., & Highton, A. J. (2010, July). Site specific memory T cells generated from slow antigen release vaccination. Verbal presentation at the New Zealand Australasian Society for Immunology (NZ ASI) Branch Meeting, Wellington, New Zealand.
Girardin, A., Phillips, V., Anjomshoaa, A., McCall, J., Dunbar, P. R., Reeve, A., Yoon, H.-S., & Kemp, R. (2010, May). T cell mediated immune responses in colorectal cancer patients. Verbal presentation at the New Zealand Society for Oncology (NZSO) Annual Meeting, Auckland, New Zealand.
2009
Conference Contribution - Published proceedings: Abstract
Kemp, R. A., Yoon, H.-S., Anjomshoaa, A., & Reeve, A. E. (2009). Using T cell responses in the lymph node to predict patient outcome in colorectal cancer. Journal of Immunology. 182(Meeting Abstracts 1). [Abstract]
Ting, Y., Coates, P. T., Marti, H., Dunn, A. C., Parker, R. M., Jack, R. W., Kemp, R. A., Walker, R. J., & McLellan, A. D. (2009). Urinary soluble HLA-DR is a potential biomarker for acute renal transplant rejection. Proceedings of the Australasian Society for Immunology 39th Annual Scientific Meeting. ASI. Retrieved from http://www.asi2009.org/
Saunderson, S. C., Kemp, R. A., & McLellan, A. D. (2009). CD169 (sialoadhesin) mediates sialic acid-dependent binding of exosomes to marginal zone metallophilic macrophages and subcapsular sinus macrophages. Proceedings of the Australasian Society for Immunology 39th Annual Scientific Meeting. ASI. Retrieved from http://www.asi2009.org/
Kemp, R. A., Yoon, H.-S., Phillips, V., Anjomshoaa, A., & Reeve, A. E. (2009). Using T cell responses in the lymph node to predict patient outcome in colorectal cancer. Proceedings of the Australasian Society for Immunology 39th Annual Scientific Meeting. ASI. Retrieved from http://www.asi2009.org/
Bouwer, A. L., Stoitzner, P., Kemp, R. A., & McLellan, A. D. (2009). Natural killer cells activate CD8+ T cells at both the priming and challenge phases of an anti-tumour response. Proceedings of the Australasian Society for Immunology 39th Annual Scientific Meeting. ASI. Retrieved from http://www.asi2009.org/
Conference Contribution - Verbal presentation and other Conference outputs
Kemp, R. (2009, November). Vaccination strategies to enhance T cell memory responses. Verbal presentation at the National Immunisation Conference, Auckland, New Zealand.
2008
Conference Contribution - Poster Presentation (not in published proceedings)
Kemp, R., Yoon, H.-S., Phillips, V., Anjomshoaa, A., & Reeve, A. (2008, December). Using T cell responses in the lymph node to predict patient outcome in colorectal cancer. Poster session presented at the Australasian Society for Immunology 38th Annual Scientific Meeting, Canberra, Australia.
Conference Contribution - Verbal presentation and other Conference outputs
Kemp, R., Yoon, H.-S., Phillips, V., Anjomshoaa, A., & Reeve, A. (2008, December). Using T cell responses in the lymph node to predict patient outcome in colorectal cancer. Verbal presentation at the Australasian Society for Immunology 38th Annual Scientific Meeting, Canberra, Australia.
Kemp, R. A., & Seddon, B. P. (2008, June). STAT5 activation is necessary but not sufficient for CD8+ memory T cell formation and maintenance. Verbal presentation at the New Zealand Australasian Society for Immunology (NZ ASI) Branch Meeting, Wellington, New Zealand.
2005
Journal - Research Article
Kemp, R. A., Bäckström, B. T., & Ronchese, F. (2005). The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity. Immunology, 115(3), 315-324. doi: 10.1111/j.1365-2567.2005.02168.x
2004
Journal - Research Article
Begg, D., Kemp, R. A., & Griffin, F. (2004). Normal levels of immunocompetence in possums (Trichosurus vulpecula) exposed to different laboratory housing conditions post capture. Immunology & Cell Biology, 82, 253-256. doi: 10.1046/j.1440-1711.2004.01219.x
2001
Journal - Research Article
Kemp, R. A., & Ronchese, F. (2001). Tumor-specific Tc1 but not Tc2 cells deliver protective anti-tumor immunity. Journal of Immunology, 167, 6497-6502.
Chtanova, T., Kemp, R. A., Sutherland, A., Ronchese, F., & Mackay, C. (2001). Gene microarrays reveal extensive differential gene expression in both CD4+ and CD8+ type 1 and type 2 T cells. Journal of Immunology, 167, 3057-3063.
2000
Journal - Research Article
Ritchie, D., Hermans, I., Lumsden, J., Scanga, C., Roberts, J., Yang, J., Kemp, R. A., & Ronchese, F. (2000). Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo. Journal of Immunological Methods, 256, 109-117.
1998
Journal - Research Article
Bremer, P. J., Osborne, C. M., Smith, J. J., & Kemp, R. A. (1998). Survival of Listeria monocytogenes in seawater and affect of seawater exposure on thermal resistance. Journal of Applied Microbiology, 85(3), 545-553.
Bremer, P. J., Osborne, C. M., & Kemp, R. A. (1998). Thermal-death times of Hafnia alvei cells in a model suspension and in artifically contaminated hot smoked Kahawai (Arripis trutta). Journal of Food Protection, 61(8), 1047-1051.
1997
Conference Contribution - Verbal presentation and other Conference outputs
Osborne, C. M., Kemp, R. A., Bremer, P. J., & Fletcher, G. C. (1997, July). Control of histamine forming bacteria (Hafnia alvei)during the production of hot smoked kahawai. Verbal presentation at the New Zealand Institute of Food Science and Technology National Conference, Napier.
Bremer, P. J., Osborne, C. M., Kemp, R. A., & Smith, J. J. (1997, July). Survival, recoverability, sublethal injury and alteration of thermal death point of Listeria monocytogenes on exposure to seawater. Verbal presentation at the New Zealand Institute of Food Science and Technology National Conference, Napier.